Phage Lab

Macul, Chile Founded: 2010 • Age: 16 yrs
Bacteriophage treatments for animal infections are developed by the company.

About Phage Lab

Phage Lab is a company based in Macul (Chile) founded in 2010 by Diego Belmar, Nicolas Ferreira, and Hans Pieringer.. Phage Lab has raised $41 million across 2 funding rounds from investors including Collab Fund, Waterlemon Ventures and Kevin Efrusy. Phage Lab offers products and services including INSPEKTOR, FÓRMIDA, and PHAGEIN. Phage Lab operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Avecho and Aquilón Cyl, among others.

  • Headquarter Macul, Chile
  • Founders Diego Belmar, Nicolas Ferreira, Hans Pieringer
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Phagelab Chile Spa
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $41 M (USD)

    in 2 rounds

  • Latest Funding Round
    $11 M (USD), Series A

    Jan 23, 2024

  • Investors
    Collab Fund

    & 5 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Phage Lab

Phage Lab offers a comprehensive portfolio of products and services, including INSPEKTOR, FÓRMIDA, and PHAGEIN. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Analyzes bacteria for virulence, resistance, and origins in industrial settings.

Applies bacteriophage combinations to control specific bacteria on farms.

Generates actionable data on bacteria using AI for farm interventions.

People of Phage Lab
Headcount 10-50
Employee Profiles 14
Employee Profiles
People
Hans Pieringer
CEO
People
Sabrina Torgan
CFO
People
Pablo Cifuentes
CTO
People
Barbara Godoy
Head of Research Quality Assurance

Unlock access to complete

Funding Insights of Phage Lab

Phage Lab has successfully raised a total of $41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $11.0M
  • First Round

    (23 May 2022)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Series A - Phage Lab Valuation Collab Fund , Waterlemon
May, 2022 Amount Series A - Phage Lab Valuation Kaszek , Humboldt Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Phage Lab

Phage Lab has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Collab Fund, Waterlemon Ventures and Kevin Efrusy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Private equity firm investing in multiple sectors
Founded Year Domain Location
A venture capital fund focused on climate innovation startups.
Founded Year Domain Location
Venture capital firm focused on empowering Latin American founders.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Phage Lab

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Phage Lab

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Phage Lab Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Phage Lab

Phage Lab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Avecho and Aquilón Cyl, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
domain founded_year HQ Location
Animal health therapeutics are developed and supplied globally by Ceva.
domain founded_year HQ Location
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
domain founded_year HQ Location
Developer of a drug delivery system for the safety of the animal and human health
domain founded_year HQ Location
Products enhancing animal productivity are developed and marketed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Phage Lab

Frequently Asked Questions about Phage Lab

When was Phage Lab founded?

Phage Lab was founded in 2010 and raised its 1st funding round 12 years after it was founded.

Where is Phage Lab located?

Phage Lab is headquartered in Macul, Chile. It is registered at Macul, Region Metropolitana De Santiago, Chile.

Who is the current CEO of Phage Lab?

Hans Pieringer is the current CEO of Phage Lab. They have also founded this company.

Is Phage Lab a funded company?

Phage Lab is a funded company, having raised a total of $41M across 2 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on May 23, 2022.

What does Phage Lab do?

Founded in 2010 and based in Macul, Chile, bacteriophage technologies are utilized by the company to create therapeutic options against bacterial infections in animals. Collaborations are maintained with production entities in the poultry, pork, livestock, and aquaculture sectors to address infection challenges. Focus is placed on alternative treatments that support industry needs without relying on traditional antibiotics.

Who are the top competitors of Phage Lab?

Phage Lab's top competitors include Zoetis, Ceva and Bio-Sourcing.

What products or services does Phage Lab offer?

Phage Lab offers INSPEKTOR, FÓRMIDA, and PHAGEIN.

Who are Phage Lab's investors?

Phage Lab has 6 investors. Key investors include Collab Fund, Waterlemon Ventures, Kevin Efrusy, Nazca, and Kaszek.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available